A new possible cure for cancer was discovered by experts from Europe. Breast cancer is the most common invasive cancer in women worldwide. It represents 16% of all female cancers and 22.9% of invasive cancers in women. 18.2% of all cancer deaths worldwide, including both males and females are breast cancer.
Professor Nigel Budred in Amsterdam presented the Herceptin and lapatinib as a potential cure for breast cancer in the event called European Cancer Conference.
Herceptin is approved for the treatment of breast cancer in early stage that is the factor-positive 2 human epidermal growth receptor (HER2 +) and has spread to lymph nodes, or is HER2 positive and has not spread to lymph nodes. If no spread to lymph nodes, the cancer needs to be estrogen receptor / progesterone receptor (ER / PR) -negative or have a high risk feature.
also eliminates the need for chemotherapy and surgery. Her hair is still at the head, his body will not change drastically and treatment will still be more effective than chemotherapy.
The results of this investigation were that 257 women diagnosed with HER2-positive breast cancer participated in the study and half of them were subjected to this treatment drug and one in the control group.
In conclusion, it was confirmed that the first group 11% were free cancer cells with only two weeks of treatment, and 17% of cases showed drastically reduced tumors.
Now, if a person with breast cancer wanted to try this method will not be able to do that because, Herceptin is only allowed to be used with chemotherapy and he is not alone, which is a big problem that hopes to change soon.
With medical advances improving every year, it is very possible that this could happen sooner than we think!